|
| |
Articles
1-84 out of 84 article(s)
| Title |
Author |
Type |
Date |
Words |
| Research and Markets: Diabetic Nephropathy - Pipeline Review, H1 2012. |
|
|
Apr 17, 2012 |
332 |
| Concert Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating CTP-499 for the Treatment of Diabetic Nephropathy. |
|
|
Mar 5, 2012 |
797 |
| Effect of loganin on experimental diabetic nephropathy. |
Jiang, Wang-Lin; Zhang, Shu-Ping; Hou, Jian; Zhu, Hai-Bo |
Report |
Mar 1, 2012 |
4397 |
| Research and Markets: Diabetic Nephropathy Global Clinical Trials Review, H2, 2011. |
|
|
Dec 23, 2011 |
339 |
| ChemoCentryx Initiates a Phase II Clinical Trial For CCX140, A Novel Inhibitor of the Chemokine Receptor CCR2 for the Treatment of Diabetic Nephropathy. |
|
|
Dec 8, 2011 |
837 |
| Serum homocysteine values are associated with diabetic foot ulcer/Serum homosistein degerleri diyabetik ayak ile iliskilidir. |
Erdogan, Mehmet; Solmaz, Soner; Canataroglu, Abdullah; Kulaksizoglu, Mustafa |
Clinical report |
Dec 1, 2011 |
3682 |
| Concert Presents Phase 1 Data for CTP-499 at ASN Kidney Week Meeting. |
|
|
Nov 14, 2011 |
881 |
| NephroGenex Announces the Successful Completion of PYR-210. |
|
|
Nov 7, 2011 |
626 |
| NephroGenex Reaches Agreement with the FDA on a Subpart H Phase 3 Program for Pyridorin(TM). |
|
|
Nov 7, 2011 |
429 |
| Concert Pharmaceuticals Announces CTP-499 Data Presentations at the American Society of Nephrology (ASN) Kidney Week Meeting. |
|
|
Oct 19, 2011 |
622 |
| Prevalence & risk factors of nephropathy in type 2 diabetic patients. |
K, Vimalkumar V.; Moses, C.R. Anand; S., Padmanaban |
Report |
Aug 1, 2011 |
1962 |
| Relypsa Begins Treatment in AMETHYST-DN Trial of RLY5016 for Hyperkalemia in Diabetic Nephropathy Patients with Chronic Kidney Disease. |
|
|
Jun 28, 2011 |
775 |
| Vitae Reports Positive Clinical Data in Chronic Kidney Disease Program at the American Diabetes Association's 71st Scientific Sessions. |
|
Clinical report |
Jun 27, 2011 |
950 |
| Research and Markets: The Diabetic Nephropathy Therapeutics Market Is Expected To Record A CAGR Of 5.2%, To Reach $2.35 Billion By 2017. |
|
|
Jun 24, 2011 |
662 |
| Concert Pharmaceuticals Announces Advancement of Novel Drug Candidates in Kidney Disease and Spasticity. |
|
Clinical report |
Jun 20, 2011 |
1007 |
| Reportlinker Adds Diabetic Nephropathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017. |
|
|
Jun 8, 2011 |
735 |
| Protective effect of turmeric (curcuma longa linn.) Powder on early diabetic nephropathy in rats. |
Bahram, Amouoghli Tabrizi; Daryoush, Mohajeri; Yousef, Doustar; Saeid, Safarmashaei |
Report |
Apr 1, 2011 |
2996 |
| Concert Pharmaceuticals Advances Novel Chronic Kidney Disease Treatment, CTP-499, in Phase 1 Clinical Study. |
|
|
Mar 29, 2011 |
672 |
| The Highest Proportion of Surveyed MCOs Select Altace and Diovan as the Safest, Most Tolerable and Most Conveniently Delivered Agents for the Treatment of Diabetic Nephropathy. |
|
|
Jan 13, 2011 |
662 |
| Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus. |
Soto, C.; Perez, J.; Garcia, V.; Uria, E.; Vadillo, M.; Raya, L. |
Report |
Dec 1, 2010 |
3529 |
| Interim Results From Independent Study of H.P. Acthar Gel in Patients With Advanced Diabetic Nephropathy Presented at American Society of Nephrology 43rd Annual Meeting. |
|
Clinical report |
Nov 22, 2010 |
1190 |
| Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment of Diabetic Kidney Disease. |
|
Clinical report |
Nov 22, 2010 |
1060 |
| Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment of Diabetic Kidney Disease. |
|
Clinical report |
Nov 22, 2010 |
1045 |
| Renoprotection in diabetes mellitus: end-stage renal disease is a common and important complication of diabetes. |
Okpechi, Ikechi G.; Swanepoel, Charles R. |
|
Oct 1, 2010 |
3054 |
| Chromium picolinate may reduce inflammation in diabetic nephropathy. |
|
|
Sep 23, 2010 |
330 |
| Roasted licorice extracts dampen high glucose-induced mesangial hyperplasia and matrix deposition through blocking Akt activation and TGF-[beta] signaling. |
Li, J.; Lee, Y.S.; Choi, J.-S.; Sung, H.-Y.; Kim, J.-K.; Lim, S.S.; Kang, Y.-H. |
Report |
Aug 1, 2010 |
6482 |
| Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor & angiotensin receptor blocker in type 1 DM with nephropathy. |
Anantharaman, R.; Bhansali, Anil; Bhadada, Sanjay K.; Kohli, Harbir S.; Dutta, Pinaki; Walia, Rama; |
Report |
Jul 1, 2010 |
3478 |
| The effects of regular aerobic exercise on renal functions in streptozotocin induced diabetic rats. |
Kurdak, Hatice; Sandikci, Sunay; Ergen, Nilay; Dogan, Ayse; Kurdak, Sanli Sadi |
Report |
Jun 1, 2010 |
3860 |
| Predialysis Hb levels are low in diabetic nephropathy patients. |
Brunk, Doug |
Brief article |
Apr 1, 2010 |
281 |
| Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats. |
Su, Jing; Zhang, Pei; Zhang, Jing-Jing; Qi, Xiang-Ming; Wu, Yong-Gui; Shen, Ji-Jia |
Report |
Mar 1, 2010 |
4509 |
| Profile of type 2 diabetic patients referred to electroneurography laboratory/Elektronorografi laboratuvarina yonlendirilen tip 2 diyabet hastalarinin profili. |
Emre, Ufuk; Unal, Aysun; Atasoy, H. Tugrul; Kiran, Sibel; Bayraktaroglu, Taner; Sumer, Murat |
Report |
Mar 1, 2010 |
3054 |
| World Kidney Day; diabetic kidney disease: act now or pay later. |
|
Report |
Feb 1, 2010 |
2500 |
| Peony and diabetic nephropathy. |
Finney-Brown, Tessa |
Report |
Dec 22, 2009 |
424 |
| Implementation of a diabetic foot management best practice guideline (BPG) in hemodialysis units. |
Prentice, Dawn; Ritchie, Linda; Crandall, Jackie; Harwood, Lori; McAuslan, Debra; Lawrence-Murphy, J |
Clinical report |
Oct 1, 2009 |
3696 |
| Renoprotective effects of the age-inhibitor pyridoxamine in experimental chronic allograft nephropathy in rats. |
|
Brief article |
Jul 1, 2009 |
295 |
| Pyridoxamine protects proteins from functional damage by 3-deoxyglucosone: mechanism of action of Pyridoxamine. |
|
Report |
Jul 1, 2009 |
261 |
| Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy. |
|
Clinical report |
Jul 1, 2009 |
262 |
| Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: common, harmful, yet underappreciated. |
Henriksen, Kammi J.; Meehan, Shane M.; Chang, Anthony |
Report |
Jul 1, 2009 |
11169 |
| Vitamin B1 helps reverse early kidney disease in diabetics. |
Dye, Dayna |
Report |
Mar 1, 2009 |
181 |
| Naturopathic approaches to diabetic kidney disease. |
Tan, Alex; Leone, Jacob |
Clinical report |
Feb 1, 2009 |
4356 |
| Diagnosing nonneoplastic lesions in nephrectomy specimens. |
Truong, Luan D.; Shen, Steven S.; Park, Moon-Hyang; Krishnan, Bhuvaneswari |
Report |
Feb 1, 2009 |
6102 |
| Candesartan does not prevent microalbuminuria. |
Walsh, Nancy |
|
Dec 1, 2008 |
678 |
| Nephropathy, mortality cut by glucose, blood pressure control. |
Freeman, Sara |
Clinical report |
Oct 1, 2008 |
541 |
| Reata Pharmaceuticals Contracts ApoCell to Detect Innovative Biomarkers in a Phase II Clinical Study of RTA 402 for Diabetic Renal Disease. |
|
Clinical report |
Jun 10, 2008 |
380 |
| Case Western Reserve University and TGen Select Affymetrix SNP Array 6.0 for Diabetes Study. |
|
|
Jun 9, 2008 |
892 |
| Target Product Profiles 2008: Physician Insights on Key Attributes - Diabetic Nephropathy. |
|
|
May 13, 2008 |
691 |
| Therapy averts contrast nephropathy in diabetes. |
Tucker, Miriam E. |
Clinical report |
May 1, 2008 |
690 |
| Gain Insight into the Pipeline Status of Diabetic Nephropathy Drugs by Company and by Stage and Also Get a Summary of the Latest News and Developments in This Area. |
|
|
Sep 14, 2007 |
375 |
| Data Supports Potential Mechanism for Gentium's Defibrotide in Cancer, Diabetic Nephropathy and Veno-Occlusive Disease. |
|
|
Jul 16, 2007 |
875 |
| William Blair & Company Initiates Coverage of Exelixis Inc. With Outperform Rating. |
|
Company overview |
Jun 29, 2007 |
372 |
| Gentium's Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology. |
|
|
Apr 23, 2007 |
561 |
| Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. |
Pucci, Laura; Triscornia, Stefano; Lucchesi, Daniela; Fotino, Carmen; Pellegrini, Giovanni; Pardini, |
|
Mar 1, 2007 |
7330 |
| Ginkgo biloba extract protects rat kidney from diabetic and hypoxic damage. |
Welt, K.; Weiss, J.; Martin, R.; Hermsdorf, T.; Drews, S.; Fitzl, G. |
Drug overview |
Feb 1, 2007 |
2962 |
| Chip electrophoresis as a method for quantifying total microalbuminuria. |
Chan, Owen T.M.; Herold, David A. |
|
Nov 1, 2006 |
3601 |
| Application of liquid chromatography-mass spectrometry technology for early detection of microalbuminuria in patients with kidney disease. |
Babic, N.; Larson, T.S.; Grebe, S.K.; Turner, S.T.; Kumar, R.; Singh, R.J. |
|
Nov 1, 2006 |
2172 |
| New Treatment a Success for Anaemia Associated With Chronic Kidney Disease. |
|
|
Sep 14, 2006 |
898 |
| Optimize blood pressure control in pregnacy with nephropathy. |
Lovinger, Sarah Pressman |
|
Jun 1, 2006 |
508 |
| Nocturnal hypertension may promote diabetic nephropathy. |
|
Disease/Disorder overview |
Jun 1, 2006 |
404 |
| Cardiac troponin T circulates in the free, intact form in patients with kidney failure. |
Fahie-Wilson, Michael N.; Carmichael, David J.; Delaney, Michael P.; Stevens, Paul E.; Hall, Elizabe |
|
Mar 1, 2006 |
4023 |
| Southern Medical Journal CME Topic: improving antihypertensive therapy in patients with diabetic nephropathy. |
|
|
Feb 1, 2006 |
576 |
| Improving antihypertensive therapy in patients with diabetic nephropathy. |
Mende, Christian W. |
|
Feb 1, 2006 |
5815 |
| Hypertension and Diabetic Kidney Disease -- Commercial Performance of Both ACE Inhibitors and ARBS is Dependent on Renoprotective Benefits beyond Blood Pressure Control. |
|
|
Dec 23, 2005 |
339 |
| Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples. |
Brinkman, Jacoline W.; de Zeeuw, Dick; Duker, Jacko J.; Gansevoort, Ronald T.; Kema, Ido P.; Hillege |
|
Nov 1, 2005 |
2772 |
| SPP301 Phase IIb Data to Be Presented at American Society of Nephrology Meeting. |
|
|
Oct 28, 2005 |
1185 |
| Keryx Biopharmaceuticals, Inc, Announces Final Phase II Data Presentation on KRX-101 at the Upcoming American Society of Nephrology Renal Week. |
|
|
Oct 24, 2005 |
665 |
| Growing Incidence of Acute Renal Failure Fuels Growth in the European Renal Therapy Market. |
|
Industry Overview |
Oct 18, 2005 |
923 |
| Growing Incidence of Acute Renal Failure Fuels Growth in the European Renal Therapy Market. |
|
Industry Overview |
Oct 18, 2005 |
924 |
| High body mass index linked to chronic kidney disease. |
Tucker, Miriam E. |
|
Aug 1, 2005 |
444 |
| Incidence of ESRD in diabetics has dropped 30%. |
Brunk, Doug |
|
Aug 1, 2005 |
494 |
| New drug may aid diabetic nephropathy. |
Brunk, Doug |
|
Aug 1, 2005 |
413 |
| Secondary analyses in obesity, diabetes, digestive and kidney diseases. |
|
|
Jul 1, 2005 |
1220 |
| Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes. |
Herrmann, Wolfgang; Schorr, Heike; Obeid, Rima; Makowiski, Julia; Fowler, Brian; Kuhlmann, Martin K. |
|
May 1, 2005 |
5243 |
| ARB equals ACE inhibitor in diabetic nephropathy. |
Jancin, Bruce |
|
Jan 1, 2005 |
647 |
| Leptin to treat lipodystrophy. |
|
|
Jan 1, 2005 |
116 |
| Early diabetic nephropathy marker. |
MacReady, Norra |
|
Oct 15, 2004 |
314 |
| Leptin to treat lipodystrophy. |
|
|
May 1, 2004 |
115 |
| Time-resolved fluorescence resonance energy transfer assay for point-of-care testing of urinary albumin. |
Qin, Qiu-Ping; Peltola, Olli; Pettersson, Kim |
|
Jul 1, 2003 |
5749 |
| Hypertension a critical issue. (Health). |
Ungar, Linda |
|
Mar 1, 2003 |
877 |
| Kidney disease of diabetes. |
|
Pamphlet |
Apr 1, 2001 |
2778 |
| Cardiac troponin T predicts long-term outcomes in hemodialysis patients. |
Ooi, Daylily S.; Zimmerman, Deborah; Graham, Janet; Wells, George A. |
Clinical report |
Mar 1, 2001 |
4246 |
| Prevent diabetes problems: Keep your kidneys healthy. |
|
Pamphlet |
May 17, 2000 |
1908 |
| Influence of repetitive finger puncturing on skin perfusion and capillary blood analysis in patients with diabetes mellitus. |
de Graaff, Jurgen C.; Hemmes, Geesje J.; Bruin, Taco; Ubbink, Dirk T.; Michels, Robert P.J.; Jacobs, |
Report |
Dec 1, 1999 |
4144 |
| Cardiac troponin T in hemodialyzed patients. |
Ooi, Daylily S.; House, Andrew A. |
Clinical report |
Jul 1, 1998 |
4446 |
| Kidney disease of diabetes. |
|
Pamphlet |
Jul 1, 1995 |
2527 |
|
